Long-term Caspase-2 inhibition in liver may increase cancer risk despite short-term benefits
📰 Original title: A promising fatty liver treatment may raise cancer risk
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️
View full AI summary: https://killbait.com/en/long-term-caspase-2-inhibition-in-liver-may-increase-cancer-risk-despite-short-term-benefits/?redirpost=9a45bed1-ff1e-44cb-86eb-04e9e959167c

Long-term Caspase-2 inhibition in liver may increase cancer risk despite short-term benefits
A recent study from the University of Adelaide reveals potential long-term risks associated with blocking the enzyme Caspase-2, a strategy previously thought to help treat fatty liver disease.